INTRANODAL TREATMENT WITH IFNΑ-DENDRITIC CELLS AND RITUXIMAB INDUCES SYSTEMIC CLINICAL RESPONSE AND ENDOGENOUS VACCINATION AGAINST FOLLICULAR LYMPHOMA: FINAL RESULT OF A PHASE I STUDY

Authors :: Mauro Mattei
Davide Carlei
A. di Napoli
Luciano Castiello
Carmela Rozera
Riccardo Dolcetti
Massimo Spada
Agostino Tafuri
Francesca Spadaro
Stefano M. Santini
Laura Santodonato
Giuseppina D'Agostino
C. Cox
Domenica M. Monque
Caterina Lapenta
Daniela Prosperi
Simona Donati
Michela Cangemi
Filippo Belardelli
Enrica Montefiore
Antonio Pavan
F. Di Landro
S. Borgioni
Paolo Castaldo
Luigi Ruco
Eleonora Aricò
Imerio Capone
Elena Muraro
Debora Martorelli
Paola Sestili
Stefan Hohaus
C Berdini
Source :: Hematological Oncology. 37:317-318
Publication Year :: 2019
Publisher :: Wiley, 2019.

Subjects :: Cancer Research
business.industry
Follicular lymphoma
Endogeny
Hematology
General Medicine
medicine.disease
Phase i study
Vaccination
Oncology
Cancer research
medicine
Rituximab
business
medicine.drug

Full Text Access

Tools